Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda today announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy.
28 Oct 2021
United Kingdom
Crick news

To view this News Article please log in or create a profile

Similar stories

We are sorry to announce that Sir David Cooksey, Chairman of the Francis Crick Institute from 2009–2017, has passed away at the age of 83. More...

Do you know a second year undergraduate looking for hands-on research training? More...

We are pleased to announce that Jean-Baptiste Cazier will join the Crick on Tuesday 2 January as Head of Bioinformatics … More...

We are pleased to be launching the Crick's new Sustainability Strategy for 2023-2028, which has been created in response… More...

Yes, that is the 5th floor hub in the background!

On Friday 3 November, the Crick was transformed into a TV studio for the live broadcast of Channel 4’s Stand Up To Cance… More...

Have your say


Contact us

The Francis Crick Institute
1 Midland Road

This website is powered by